Breast Neoplasms
- Name
- Breast Neoplasms
- Accession Number
- DBCAT001793
- Description
Not Available
- Drugs
Drug Drug Description Pertuzumab An antineoplastic agent used in the treatment of HER2-positive metastatic breast cancer in combination with other antineoplastic agents. Alpelisib Alpelisib is indicated in combination with fulvestrant to treat postmenopausal women, and men, with advanced or metastatic breast cancer. This cancer must be hormone receptor (HR)-positive, human epidermal growth factor... - Drugs & Drug Targets